These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7207508)

  • 41. [Characterization, by chromatography on DEAE-sephadex, of fructose-1,6-diphosphate aldolase of normal adult and fetal muscle and muscle of subjects with progressive muscular dystrophy of the Duchenne type].
    Idéo G; Cao A
    Boll Soc Ital Biol Sper; 1966 Jun; 42(11):693-6. PubMed ID: 5967932
    [No Abstract]   [Full Text] [Related]  

  • 42. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
    Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
    Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histo- and cyto-enzymatic aspects of polymyositis and of progressive muscular dystrophy. Preliminary note].
    De Giacomo P; Perniola T
    Acta Neurol (Napoli); 1971; 26(3):375-80. PubMed ID: 5094473
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle breakdown and lysosomal activation (biochemistry).
    Pearson CM; Kar NC
    Ann N Y Acad Sci; 1979; 317():465-77. PubMed ID: 289325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creatine phosphokinase activity and its isozymes in normal, fetal and Duchenne dystrophic muscle.
    Karandikar PV; Varadkar AM; Desai AD; Potnis AV
    J Postgrad Med; 1980 Jan; 26(1):63-7. PubMed ID: 7373565
    [No Abstract]   [Full Text] [Related]  

  • 47. [Aldolase acitivity in subcellular muscle particles in experimental muscular dystrophy and in normal conditions].
    Grigor'eva VA; Medovar EN
    Vopr Med Khim; 1966; 12(2):193-6. PubMed ID: 6001585
    [No Abstract]   [Full Text] [Related]  

  • 48. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture.
    Mawatari S; Miranda A; Rowland LP
    Neurology; 1976 Nov; 26(11):1021-6. PubMed ID: 988507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenylosuccinase deficiency.
    Van den Berghe G; Jaeken J
    Adv Exp Med Biol; 1986; 195 Pt A():27-33. PubMed ID: 3014834
    [No Abstract]   [Full Text] [Related]  

  • 53. Muscle MRI in inherited neuromuscular disorders: past, present, and future.
    Mercuri E; Pichiecchio A; Allsop J; Messina S; Pane M; Muntoni F
    J Magn Reson Imaging; 2007 Feb; 25(2):433-40. PubMed ID: 17260395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzyme histochemistry of muscle, with special reference to the Duchenne type of muscular dystrophy (a preliminary communication).
    Janaki S; Susheela AK
    Neurol India; 1966; 14(4):174-7. PubMed ID: 5977714
    [No Abstract]   [Full Text] [Related]  

  • 55. [Correlation between functional disability, age, and serum enzymes in neuromuscular diseases].
    Werneck LC
    Arq Neuropsiquiatr; 1995 Mar; 53(1):60-8. PubMed ID: 7575210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5'-nucleotidase activity in Duchenne muscular dystrophy.
    Scholte HR; Busch HF
    N Engl J Med; 1979 Sep; 301(13):726. PubMed ID: 481473
    [No Abstract]   [Full Text] [Related]  

  • 57. Kinetic studies of mutant human adenylosuccinase.
    Barshop BA; Alberts AS; Gruber HE
    Biochim Biophys Acta; 1989 Nov; 999(1):19-23. PubMed ID: 2804136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Muscle fiber immaturity and inactivity reduce myonecrosis in Duchenne muscular dystrophy.
    Kimura S; Sugino S; Ohtani Y; Matsukura M; Nishino I; Ikezawa M; Sakata A; Kondo Y; Yoshioka K; Huard J; Nonaka I; Miike T
    Ann Neurol; 1998 Dec; 44(6):967-71. PubMed ID: 9851444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The principles of gene therapy in Duchenne muscular dystrophy.
    Karpati G; Acsadi G
    Clin Invest Med; 1994 Oct; 17(5):499-509. PubMed ID: 7867254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lysosomal enzyme activities in skeletal muscle of patients with neuromuscular diseases.
    Kawai H; Yoneda K; Naruo T; Nishida Y; Kashiwagi S; Kunishige M; Saito S
    Muscle Nerve; 1995 Sep; 18(9):1009-15. PubMed ID: 7643862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.